Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
4
|
pubmed:dateCreated |
1991-4-19
|
pubmed:abstractText |
Changes in the radiation age response are described in two cell lines derived from human squamous cell carcinomas. A radioresistant tumor cell line, JSQ-3, has a DO of 240 cGy and is polyploid with a DNA content of 2.68. A relatively radiosensitive tumor cell line, SCC-61, has a DO of 126 cGy and has a DNA index of 1.16. Tumor cells were separated and synchronized by centrifugal elutriation; flow cytometry was used to determine cell-cycle parameters and relative synchrony. The radioresistant cell line, JSQ-3B, was found to have twice the number of cells in S-phase than the more sensitive cell line (28% and 13% for JSQ-3B and SCC-61B, respectively). Both cell lines, despite differences in intrinsic radiosensitivity, were most resistant during S-phase (DOs of 258 and 157 cGy for JSQ-3B and SCC-61B, respectively) and were maximally sensitive during G1 (DOs of 193 and 95 cGy for JSQ-3B and SCC-61B, respectively). Clinical implications of our findings are discussed.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:status |
MEDLINE
|
pubmed:month |
Apr
|
pubmed:issn |
0360-3016
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
20
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
733-8
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:2004949-Carcinoma, Squamous Cell,
pubmed-meshheading:2004949-Cell Cycle,
pubmed-meshheading:2004949-Cell Division,
pubmed-meshheading:2004949-Cell Line,
pubmed-meshheading:2004949-Cell Survival,
pubmed-meshheading:2004949-Dose-Response Relationship, Drug,
pubmed-meshheading:2004949-Head and Neck Neoplasms,
pubmed-meshheading:2004949-Humans,
pubmed-meshheading:2004949-Tumor Stem Cell Assay
|
pubmed:year |
1991
|
pubmed:articleTitle |
Variation in radiation sensitivity during the cell cycle of two human squamous cell carcinomas.
|
pubmed:affiliation |
Department of Radiation and Cellular Oncology, Michael Reese Medical Center, Chicago, IL.
|
pubmed:publicationType |
Journal Article,
Comparative Study
|